Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06366269
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-04-10
Brief Title:
Acupuncture First for ICBPS
Sponsor:
David Sheyn
Organization:
University Hospitals Cleveland Medical Center
Study Overview
Official Title:
Acupuncture as First-line Therapy for Patients With Interstitial CystitisPainful Bladder Syndrome
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if acupuncture in addition to behavioral changes can better treat in women with bladder pain syndrome also known as interstitial cystitis that have not received other treatments The main question it aims to answer is
Does acupuncture improve pain symptoms on the Interstitial Cystitis Index Researchers will compare six 6 weeks behavioral management alone to behavioral management and acupuncture
Participants will
complete surveys about their bladder pain symptoms
make behavioral changes that have been shown to improve bladder pain symptoms
attend six 6 weekly acupuncture sessions
attend six 6 weekly physical therapy sessions after finishing acupuncture
Does acupuncture improve pain symptoms on the Interstitial Cystitis Index Researchers will compare six 6 weeks behavioral management alone to behavioral management and acupuncture
Participants will
complete surveys about their bladder pain symptoms
make behavioral changes that have been shown to improve bladder pain symptoms
attend six 6 weekly acupuncture sessions
attend six 6 weekly physical therapy sessions after finishing acupuncture
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None